Patents by Inventor Salvatore J. Salamone

Salvatore J. Salamone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imatinib immunoassay
    Patent number: 8263749
    Abstract: Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.
    Type: Grant
    Filed: November 2, 2011
    Date of Patent: September 11, 2012
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov
  • STABILIZED STANDARDS FOR BUSULFAN IMMUNOASSAY
    Publication number: 20120225443
    Abstract: Use of busulfan amide as stabilized standards in immunoassays for quantifying the amount of busulfan in samples of human biological fluids, methods for carrying out said immunoassay and kits for use in said immunoassay.
    Type: Application
    Filed: September 7, 2011
    Publication date: September 6, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Li Yunying
  • DOXORUBICIN IMMUNOASSAY
    Publication number: 20120214184
    Abstract: Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.
    Type: Application
    Filed: April 30, 2012
    Publication date: August 23, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Shu He
  • VINCRISTINE IMMUNOASSAY
    Publication number: 20120088312
    Abstract: Novel conjugates and immunogens derived from vincristine and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of vincristine in biological fluids.
    Type: Application
    Filed: October 8, 2010
    Publication date: April 12, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Daniel J. Cline
  • RISPERIDONE IMMUNOASSAY
    Publication number: 20120071636
    Abstract: Novel conjugates and immunogens derived from risperidone and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of risperidone and paliperidone in biological fluids.
    Type: Application
    Filed: November 29, 2011
    Publication date: March 22, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Daniel J. Cline, Howard Sard, Vishnumurthy Hegde
  • Lenalidomide and Thalidomide Immunoassays
    Publication number: 20120071632
    Abstract: Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.
    Type: Application
    Filed: November 23, 2011
    Publication date: March 22, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Howard Sard, Vishnumurthy Hegde
  • Lenalidomide and Thalidomide Immunoassays
    Publication number: 20120064549
    Abstract: Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 15, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Howard Sard, Vishnumurthy Hegde
  • IMATINIB IMMUNOASSAY
    Publication number: 20120045470
    Abstract: Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.
    Type: Application
    Filed: November 2, 2011
    Publication date: February 23, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov
  • IMATINIB IMMUNOASSAY
    Publication number: 20120045782
    Abstract: Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.
    Type: Application
    Filed: November 2, 2011
    Publication date: February 23, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov
  • Lenalidomide and thalidomide immunoassays
    Patent number: 8114621
    Abstract: Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: February 14, 2012
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Howard Sard, Vishnumurthy Hegde
  • DOXORUBICIN IMMUNOASSAY
    Publication number: 20120015385
    Abstract: Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 19, 2012
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Shu He
  • Risperidone immunoassay
    Patent number: 8088594
    Abstract: Novel conjugates and immunogens derived from risperidone and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of risperidone and paliperidone in biological fluids.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: January 3, 2012
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Daniel J. Cline, Howard Sard, Vishnumurthy Hegde
  • Doxorubicin immunoassay
    Patent number: 8084586
    Abstract: Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: December 27, 2011
    Assignee: Saladax Biomedical, Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Shu He
  • Imatinib immunoassay
    Patent number: 8076097
    Abstract: Novel conjugates and immunogens derived from imatinib and monoclonal antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of imatinib or its pharmacologically active salts in biological fluids.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: December 13, 2011
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov
  • Doxorubicin immunoassay
    Patent number: 8053205
    Abstract: Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: November 8, 2011
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Shu He
  • Stabilized standards for busulfan immunoassay
    Patent number: 8039220
    Abstract: Use of busulfan amide as stabilized standards in immunoassays for quantifying the amount of busulfan in samples of human biological fluids, methods for carrying out said immunoassay and kits for use in said immunoassay.
    Type: Grant
    Filed: September 17, 2008
    Date of Patent: October 18, 2011
    Assignee: Saladax Biomedical Inc.
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Yunying Li
  • RISPERIDONE IMMUNOASSAY
    Publication number: 20110229979
    Abstract: Novel conjugates and immunogens derived from risperidone and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of risperidone and paliperidone in biological fluids.
    Type: Application
    Filed: March 16, 2010
    Publication date: September 22, 2011
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Daniel J. Cline, Howard Sard, Vishnumurthy Hegde
  • LENALIDOMIDE AND THALIDOMIDE IMMUNOASSAYS
    Publication number: 20110223611
    Abstract: Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.
    Type: Application
    Filed: March 12, 2010
    Publication date: September 15, 2011
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Howard Sard, Vishnumurthy Hegde
  • IRINOTECAN IMMUNOASSAY
    Publication number: 20110165699
    Abstract: Novel conjugates of the pharmaceutically active metabolite of irinotecan and novel immunogens derived from this pharmaceutically active metabolite and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of the pharmaceutically active metabolite of irinotecan in biological fluids.
    Type: Application
    Filed: March 3, 2011
    Publication date: July 7, 2011
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Hongxia Zhang, Howard Sard, Vishnumurthy Hegde
  • Irinotecan Immunoassay
    Publication number: 20110136253
    Abstract: Novel conjugates of the pharmaceutically active metabolite of irinotecan and novel immunogens derived from this pharmaceutically active metabolite and monoclonal antibodies generated by these immunogens which are useful in immunoassays for the quantification and monitoring of the pharmaceutically active metabolite of irinotecan in biological fluids.
    Type: Application
    Filed: December 8, 2009
    Publication date: June 9, 2011
    Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Alexander Volkov, Hongxia Zhang, Howard Sard, Vishnumurthy Hegde